ACCP - ACCP Papers

ACCP Papers

Types of Papers

Petitions
Commentaries
White Papers
Position Statements
Guidelines
Opinion Papers
Other Documents of Interest
Research Institute Publications

Petitions

	ACCP/APhA/ASHP/PPAG Petition to BPS Requesting Recognition of Pediatric Pharmacy Practice as a Specialty	November 2012
	ACCP/APhA/ASHP Petition to BPS Requesting Recognition of Critical Care Pharmacy Practice as a Specialty	November 2012
	ACCP/APhA/ASHP Petition to BPS Requesting Recognition of Ambulatory Care Pharmacy Practice as a Speciality See Also: Proposed Revision to the Existing Specialty and Specialist Certification Framework for Pharmacy Practitioners Pharmacotherapy 2009;29(2):3e–13e Executive Summary of Ambulatory Care Pharmacy Practice Petition to BPS Appendices to Ambulatory Care Pharmacy Practice Petition to BPS Note: This is a large file and may take a few moments to load.	November 2008
	Petition for Added Qualifications in Cardiology for Board Certified Pharmacotherapy Specialists;	March 2000

Commentaries

	Qualifications of Pharmacists Who Provide Direct Patient Care: Perspectives on the Need for Residency Training and Board Certification Pharmacotherapy 2013; Article first published online: 26 APR 2013	April 2013
	ACCP-CPNP Comment Letter to CMS-Medicaid on Integrated Care Models	August 2012
	The Importance of Direct Patient Care in Advanced Pharmacy Practice Experiences Pharmacotherapy 2012;32(4):e88–e97	April 2012
	Acute Care Clinicial Pharmacy Practice: Unit- vs. Service-Based Models Pharmacotherapy 2012;32(2):e35–e44	February 2012
	Strategies for Developing Pharmacy Residents as Educators Pharmacotherapy 2011;31:65e–70e	March 2011
	The Essential Research Curriculum for Doctor of Pharmacy Degree Programs Pharmacotherapy 2010;30(9):344e–349e	August 2010
	Optimal Medication Therapy Prescribing and Management: Meeting Patients’ Needs in an Evolving Health Care System Pharmacotherapy 2010;30(11):350e–359e	July 2010
	AMA Scope of Practice Data Series: Pharmacists	April 2010
	AMA Scope of Practice Response Letter Final Joint Pharmacy Organization Letter	April 2010
	The Essential Research Curriculum for Doctor of Pharmacy Degree Programs Pre-publication Draft	April 2010
	ACCP Commentary: Postgraduate Year One (PGY1) Pharmacy Residency Program Equivalency Pharmacotherapy 2009;29(12):399e–407e See Also: ACCP Position Statement: Pharmacy Practice Residency (PGY1) Equivalency Pharmacotherapy 2009;29(12):1493–1494	June 2009
	ACCP Letter to HHS Secretary Sebelius	May 2009
	ACCP Letter to Senate Committee on Finance re: PGY-2 Funding	May 2009
	Statement of the American College of Clinical Pharmacy to the Institute of Medicine Committee on Comparative Effectiveness Research Priorities	March 2009
	Tenets of Professionalism for Pharmacy Students Pharmacotherapy 2009;29(6):757–759 See Also: The Development of Student Professionalism Pharmacotherapy 2009;29(6):749–756	November 2008
	ACCP Comments on Proposed revision to HIPAA standards for electronic claims	October 2008
	ACCP comments to Drug Enforcement Administration Proposed Rule on Electronic Prescribing of Controlled Substances	September 2008
	ACCP comments to Department of Health and Human Services on Proposed Rule concerning Health Professionals' Conscience-based Decisions	September 2008
	ACCP Response to AMA Resolution 303-08	June 2008
	Letter to Congresswoman Heather Wilson - H.R.5780 - Clinical Pharmacist Practitioner Services Coverage Act of 2008	April 2008
	The Definition of Clinical Pharmacy Pharmacotherapy 2008;28(6):816-817	January 2008
	ACCP comments to the Food and Drug Administration (FDA) regarding a proposal to make certain drugs available “Behind-the-Counter” (BTC) under the supervision of a pharmacist.	November 2007
	ACCP comments to the FDA on the Agency’s initiative to reevaluate and improve the Medication Guide program.	July 2007
	Medication Therapy Management Services: Application of the Core Elements in Ambulatory Settings	May 2007
	ACCP comments to the FDA on the proposed establishment of a national Sentinel Network for post-market surveillance for medical devices and pharmaceutical products.	May 2007
	ACCP Statement for the Record Submitted to the U.S. Senate Committee on Finance hearing on The Medicare Prescription Drug Benefit: Monitoring Early Experiences	May 2007
	ACCP Comments to the Health and Human Services (HHS) Secretary on a proposed rule that would give the agency authority to use claims information already being collected for Part D payment purposes for other research, analysis, reporting, and public health functions.	December 2006
	Utilization of the Center for the Advancement of Pharmaceutical Education Educational Outcomes, Revised Version 2004: Report of the 2005 American College of Clinical Pharmacy Educational Affairs Committee	August 2006
	Accreditation Council for Pharmacy Education Accreditation Standards and Guidelines for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree (“Standards 2007”). Comment on revised draft of standards and guidelines;	November 2005
	Statement of the American College of Clinical Pharmacy To the Institute of Medicine Committee on Identifying and Preventing Medication Errors	August 2005
	Accreditation Council for Pharmacy Education Accreditation Standards and Guidelines for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree (“Standards 2007”). Comment on first draft of revised standards;	August 2005
	CMS Comment Letter—Specialized Pharmacy Residency Funding under HIPPS	June 2005
	Medication Therapy Management Services: A Critical Review	May 2005
	Conditions of Coverage for End Stage Renal Disease	May 2005
	Accreditation Council for Pharmacy Education Accreditation Standards and Guidelines for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree (“Standards 2007”). Second comment on “Standards 2000”;	October 2004
	Medicare Part D Drug Benefit Implementation	October 2004
	Accreditation Council for Pharmacy Education Accreditation Standards and Guidelines for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree (“Standards 2007”). First comment on “Standards 2000”;	November 2003
	Final Pharmacists Provider Coalition Conferee Letter	July 2003
	Health Care Financing Administration; Hospital Conditions of Participation;	April 1998
	American Council on Pharmaceutical Education; Revised Accreditation Standards and Guidelines for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree;	September 1996
	Food and Drug Administration; Pharmaceutical Marketing and Information Exchange in Managed Care Environments;	December 1995
	Food and Drug Administration; Direct-to-Consumer Promotion of Prescription Drugs;	December 1995
	American Council on Pharmaceutical Education; Revised Accreditation Standards and Guidelines for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree;	November 1994

White Papers

Research
	Update: The Clinical Pharmacist as Principal Investigator Pharmacotherapy 2010;30(12):485e–89e	July 2010
	Training Clinical Pharmacy Scientists - Recommended Education for Pharmacists as Competitive Clinical Scientists Pharmacotherapy 2009;29(2):236–244 See Also: Training Clinical Pharmacy Scientists - Pharm.D.-only Investigators Are Critical to the Profession: Let’s Preserve the Fellowship as an Equally Important Way to Prepare Future Clinical Pharmaceutical Scientists Pharmacotherapy 2009;29(2):129–133 Training Clinical Pharmacy Scientists - Training Clinical Pharmaceutical Scientists in Today’s Highly Competitive Times: It’s Time to Commit to Change Pharmacotherapy 2009;29(2):134–137 Training Clinical Pharmacy Scientists - The pedigree is important Editorial Response	February 2009
	Ethical Issues Related to Clinical, Translational, and Health System Research Pharmacotherapy 2008;28(10):229e-243e	October 2008
	Research in Women and Special Populations Pharmacotherapy 2008;28(9):93e–113e	September 2008
	Cultural Competence in Health Care and Its Implications for Pharmacy Pharmacotherapy 2007;27(7):1062–1079 See Also: Cultural Competency in Health Care and Its Implications for Pharmacy Part 2: Emphasis on Pharmacy Systems and Practice Pharmacotherapy 2009;29(2):14e–34e	July 2007
	The State of Science and Research in Clinical Pharmacy Pharmacotherapy 2006;26(7):1027–1040	January 2006
	The Clinical Pharmacist as Principal Investigator Pharmacotherapy 2000;20(5):599–608	January 2000
	Central Issues Relevant to Clinical Pharmaceutical Scientist Training Programs. Pharmacotherapy 1992;11:257–63	January 1992
Practice
	Process Indicators of Quality Clinical Pharmacy Services During Transitions of Care Pre-Publication Draft	August 2012
	Improving Care Transitions: Current Practice and Future Opportunities for Pharmacists Pre-Publication Draft	August 2012
	Tenets for Developing Quality Measures for Ambulatory Clinical Pharmacy Services Pharmacotherapy 2011;31(7):115e–134e	July 2011
	Value of Conducting Pharmacy Residency Training—The Organizational Perspective Pharmacotherapy 2010;30(12):490e–510e	February 2010
	Rewards and Advancements for Clinical Pharmacists Pharmacotherapy 2010;30(1):68e–85e	January 2010
	Proposed Revision to the Existing Specialty and Specialist Certification Framework for Pharmacy Practitioners Pharmacotherapy 2009;29(2):3e–13e	February 2009
	Economic Evaluations of Clinical Pharmacy Services: 2001–2005 Pharmacotherapy 2008:28(11):285e–323e See Also: Where Does High-quality Research in Economic Evaluation Come From? Pharmacotherapy 2009;29(1):1–2	September 2008
	Clinical Pharmacist Competencies Pharmacotherapy 2008;28(6):806-815 See Also: The Definition of Clinical Pharmacy Pharmacotherapy 2008;28(6):816-817	January 2008
	Developing a Business-Practice Model for Pharmacy Services in Ambulatory Settings Pharmacotherapy 2008;28(2):7e-34e	September 2007
	Critical Pathways: The Role of Pharmacy Today and Tomorrow Pharmacotherapy 2006;26(9):1358–1368	February 2006
	Future Clinical Pharmacy Practitioners Should Be Board-Certified Specialists Pharmacotherapy 2006;26(12):1816–1825	January 2006
	Pharmacy Practice, Research, Education, and Advocacy for Older Adults Pharmacotherapy 2005;25(10):1396–1430	January 2005
	Healthy People 2010: Challenges, Opportunities, and a Call to Action for America's Pharmacists Pharmacotherapy 2004;24(9):1241–1294	January 2004
	Evidence of the Economic Benefit of Clinical Pharmacy Services: 1996–2000 Pharmacotherapy 2003;23(1):113–32	January 2003
	White Paper on Herbal Products Pharmacotherapy 2000;20(7):877–91	February 2000
	A Vision of Pharmacy's Future Roles, Responsibilities, and Manpower Needs in the United States Pharmacotherapy 2000;20:991–1020	January 2000
	Economic Evaluations of Clinical Pharmacy Services—1988–1995 Pharmacotherapy 1996;16(6):1188–1208	December 1996
	Rewards and Advancements for Clinical Pharmacy Practitioners. Pharmacotherapy 1995;15:99–105	January 1995
	Establishing and Evaluating Clinical Pharmacy Services in Primary Care. Pharmacotherapy 1994;14:743–58	January 1994
	Template for the Evaluation of a Clinical Pharmacist. Pharmacotherapy 1993;13:661–7	January 1993
	Clinical Pharmacy Practice in the Noninstitutional Setting. Pharmacotherapy 1992;12:358–64	January 1992
	Prospectus on the Economic Value of Clinical Pharmacy Services. Pharmacotherapy 1989;9:45–56	December 1989
Education
	Interprofessional Education: Principles and Application. A Framework for Clinical Pharmacy Pharmacotherapy 2009;29(3):145e–164e See Also: Interprofessional Education and Practice Pharmacotherapy 2009;29(7):880–881	December 2008
	The Development of Student Professionalism Pharmacotherapy 2009;29(6):749–756 See Also: Tenets of Professionalism for Pharmacy Students Pharmacotherapy 2009;29(6):757–759	December 2008
	Quality Experiential Education Pharmacotherapy 2008;28(10):219e-227e See Also: Ensuring Quality Experiential Education Pharmacotherapy 2008;28(12):1548–1551	October 2008
	Essential Components of a Faculty Development Program for Pharmacy Practice Faculty Pharmacotherapy 2008:28(10):245e-268e See Also: Clinical Faculty Development Pharmacotherapy 2009;29(1):124–126	October 2007

Position Statements

	Board Certification of Pharmacist Specialists Pharmacotherapy 2011;31(11):1146–1149	November 2011
	Organizational Guidance: Accepting Commercial Support See Also: April 12, 2010 Open Letter from ACCP President James Tisdale	April 2010
	Interprofessional Education and Practice Pharmacotherapy 2009;29(7):880–881 See Also: Interprofessional Education: Principles and Application. A Framework for Clinical Pharmacy Pharmacotherapy 2009;29(3):145e–164e	July 2009
	ACCP Position Statement: Pharmacy Practice Residency (PGY1) Equivalency Pharmacotherapy 2009;29(12):1493–1494 See Also: ACCP Commentary: Postgraduate Year One (PGY1) Pharmacy Residency Program Equivalency Pharmacotherapy 2009;29(12):399e–407e	June 2009
	Pharmacists and Industry: Guidelines for Ethical Interactions Pharmacotherapy 2008;28(3):410–420	January 2008
	Ensuring Quality Experiential Education Pharmacotherapy 2008;28(12):1548–1551 See Also: Quality Experiential Education Pharmacotherapy 2008;28(10):219e-227e	October 2007
	Clinical Faculty Development Pharmacotherapy 2009;29(1):124–126 See Also: Essential Components of a Faculty Development Program for Pharmacy Practice Faculty Pharmacotherapy 2008:28(10):245e-268e	October 2007
	Pharmacy Technician Education, Training, and Certification	August 2007
	The Research Agenda of the American College of Clinical Pharmacy Pharmacotherapy 2007;27(2):312–324	January 2007
	American College of Clinical Pharmacy’s Vision of the Future: Postgraduate Pharmacy Residency Training as a Prerequisite for Direct Patient Care Practice. Pharmacotherapy 2006;26(5):722–733	January 2006
	Prerogative of a Pharmacist to Decline to Provide Professional Services Based on Conscience	August 2005
	Medication Therapy Management Services Definition and Program Criteria	July 2004
	Importation of Prescription Medications	January 2004
	A Medicare Outpatient Pharmacy Benefit	January 2003
	Collaborative Drug Therapy Management by Pharmacists—2003 Pharmacotherapy 2003;23(9):1210–1225	January 2003
	Position Paper on Critical Care Pharmacy Services. Pharmacotherapy 2000;20(11):1400–1406	December 2000
	Collaborative Drug Therapy Management by Pharmacists. Pharmacotherapy 1997;17:1050–61	December 1991

Guidelines

	Guidelines for Resident Teaching Experiences Pharmacotherapy 2013; Article first published online: 11 FEB 2013	February 2013
	Desired Professional Development Pathways for Clinical Pharmacists Pharmacotherapy 2013;33(4):e34–e42	December 2012
	Joint ACCP and ISPOR Guidelines for Pharmacoeconomic and Outcomes Research Fellowship Training Programs Pharmacotherapy 2008;28(10):269e–276e	October 2007
	Guidelines for Therapeutic Interchange—2004 Pharmacotherapy 2005;25(11):1666-1680	December 2005
	Guidelines for Clinical Research Fellowship Training Programs.	October 2004
	Practice Guidelines for Pharmacotherapy Specialists. Pharmacotherapy 2000;20:487–90	December 2000
	ASHP-ACCP Supplemental Standard and Learning Objectives for Residency Training in Pharmacotherapy Practice Pharmacotherapy 1999;19(11):1336–1348	December 1999

Opinion Papers

	Over-the-Counter Access to Emergency Contraception without Age Restriction: An Opinion of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy Pharmacotherapy 2013;33(5):549–557	May 2013
	Clinical Pharmacy Services in Heart Failure: An Opinion Paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network Pharmacotherapy 2013;33(5):529–548	May 2013
	Recommendations for Training, Credentialing, and Documenting and Justifying Critical Care Pharmacy Services Pharmacotherapy 2011;31(8):135e–175e	June 2011
	Changing Oral Contraceptives from Prescription to Over-the-Counter Status Pharmacotherapy 2011;31(4):424–437	April 2011
	Recommendations for Training and Certification for Pharmacists Practicing, Mentoring, and Educating in Infectious Diseases Pharmacotherapy Pharmacotherapy 2009;29(4):482–488	October 2008
	Management of Chronic Nonmalignant Pain with Nonsteroidal Antiinflammatory Drugs Pharmacotherapy 2008;28(6):788–805	October 2008
	Caring for Patients with Chronic Kidney Disease: A Joint Opinion of the Ambulatory Care and the Nephrology Practice and Research Networks of the American College of Clinical Pharmacy Pharmacotherapy 2005;25(1):123–143	December 2005
	Pediatric Pharmacotherapeutic Education: Current Status and Recommendations to Fill the Growing Need Pharmacotherapy 2005;25(9):1277–1282	January 2005
	Women's Health PRN: Phytoestrogens as Therapeutic Alternatives to Traditional Hormone Replacement in Postmenopausal Women Pharmacotherapy 2000;20:981–90	December 2000
	CNS PRN: The Ketogenic Diet. Pharmacotherapy 1999;19(6):782–6	December 1999

ACCP Papers

Research

Practice

Education